Key Points
- EVP Kevin Herbert sold 2,000 shares of Nature's Sunshine Products at an average price of $20.68, totaling $41,360. After the sale, he still owned 48,866 shares worth about $1.01 million.
- The stock was down 2.3% and opened at $20.04, well below its 50-day and 200-day moving averages of $23.68 and $23.81, respectively.
- Recent quarterly results beat expectations, with EPS of $0.30 versus the $0.20 consensus and revenue of $122.89 million slightly above estimates. Analysts currently have a consensus rating of “Moderate Buy” with a $35 price target.
Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Kevin Herbert sold 2,000 shares of the business's stock in a transaction on Friday, June 12th. The shares were sold at an average price of $20.68, for a total transaction of $41,360.00. Following the sale, the executive vice president directly owned 48,866 shares of the company's stock, valued at $1,010,548.88. This represents a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Nature's Sunshine Products Trading Down 2.3%
Shares of Nature's Sunshine Products stock opened at $20.04 on Tuesday. The company has a fifty day moving average price of $23.68 and a 200 day moving average price of $23.81. Nature's Sunshine Products, Inc. has a twelve month low of $12.97 and a twelve month high of $28.14. The stock has a market cap of $352.30 million, a price-to-earnings ratio of 18.22 and a beta of 0.86.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.30 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.10. Nature's Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The firm had revenue of $122.89 million during the quarter, compared to analysts' expectations of $122.15 million.
Wall Street Analysts Forecast Growth
NATR has been the subject of a number of research reports. Weiss Ratings cut shares of Nature's Sunshine Products from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Tuesday, June 9th. Canaccord Genuity Group set a $37.00 price target on shares of Nature's Sunshine Products in a research report on Friday, May 8th. Finally, DA Davidson reaffirmed a "buy" rating and set a $33.00 price target on shares of Nature's Sunshine Products in a research report on Monday, May 11th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $35.00.
Check Out Our Latest Report on Nature's Sunshine Products
Hedge Funds Weigh In On Nature's Sunshine Products
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. State of Alaska Department of Revenue purchased a new position in Nature's Sunshine Products in the 4th quarter valued at about $31,000. New York State Teachers Retirement System purchased a new position in Nature's Sunshine Products in the 1st quarter valued at about $37,000. Clearstead Advisors LLC boosted its position in Nature's Sunshine Products by 16,025.0% in the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company's stock valued at $42,000 after buying an additional 1,923 shares during the last quarter. McIlrath & Eck LLC purchased a new position in Nature's Sunshine Products in the 1st quarter valued at about $48,000. Finally, Raymond James Financial Inc. purchased a new position in Nature's Sunshine Products in the 2nd quarter valued at about $37,000. 79.40% of the stock is owned by hedge funds and other institutional investors.
Nature's Sunshine Products Company Profile
(
Get Free Report)
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
